Literature DB >> 28921462

Bifidobacterium pseudocatenulatum CECT 7765 Ameliorates Neuroendocrine Alterations Associated with an Exaggerated Stress Response and Anhedonia in Obese Mice.

Ana Agusti1,2, A Moya-Pérez3,4, I Campillo3,4, S Montserrat-de la Paz3,4, V Cerrudo3,4, A Perez-Villalba3,4, Yolanda Sanz5,6.   

Abstract

Obesity, besides being a problem of metabolic dysfunction, constitutes a risk factor for psychological disorders. Experimental models of diet-induced obesity have revealed that obese animals are prone to anxious and depressive-like behaviors. The present study aimed to evaluate whether Bifidobacterium pseudocatenulatum CECT 7765 could reverse the neurobehavioral consequences of obesity in a high-fat diet (HFD) fed mouse model via regulation of the gut-brain axis. Adult male wild-type C57BL-6 mice were fed a standard diet or HFD, supplemented with either placebo or the bifidobacterial strain for 13 weeks. Behavioral tests were performed, and immune and neuroendocrine parameters were analyzed including leptin and corticosterone and their receptors, Toll-like receptor 2 (TLR2) and neurotransmitters. We found that obese mice showed anhedonia (p < 0.050) indicative of a depressive-like behavior and an exaggerated hypothalamic-pituitary axis (HPA)-mediated stress response to acute physical (p < 0.001) and social stress (p < 0.050), but these alterations were ameliorated by B. pseudocatenulatum CECT 7765 (p < 0.050). These behavioral effects were parallel to reductions of the obesity-associated hyperleptinemia (p < 0.001) and restoration of leptin signaling (p < 0.050), along with fat mass loss (p < 0.010). B. pseudocatenulatum CECT 7765 administration also led to restoration of the obesity-induced reductions in adrenaline in the hypothalamus (p < 0.010), involved in the hypothalamic control of energy balance. Furthermore, the bifidobacterial strain reduced the obesity-induced upregulation of TLR2 protein or gene expression in the intestine (p < 0.010) and the hippocampus (p < 0.050) and restored the alterations of 5-HT levels in the hippocampus (p < 0.050), which could contribute to attenuating the obesity-associated depressive-like behavior (p < 0.050). In summary, the results indicate that B. pseudocatenulatum CECT 7765 could play a role in depressive behavior comorbid with obesity via regulation of endocrine and immune mediators of the gut-brain axis.

Entities:  

Keywords:  Bifidobacterium; Depression; Microbiota; Obesity; Serotonin; Stress; TLR2

Mesh:

Substances:

Year:  2017        PMID: 28921462     DOI: 10.1007/s12035-017-0768-z

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  72 in total

1.  Increased resistance of immobilized-stressed mice to infection: correlation with behavioral alterations.

Authors:  Sayantika Mahanti; Arnab Majhi; Sharmalika Chongdar; Kiran Kundu; Kallol Dutta; Anirban Basu; Biswadev Bishayi
Journal:  Brain Behav Immun       Date:  2012-11-09       Impact factor: 7.217

Review 2.  Mechanisms for the activation of Toll-like receptor 2/4 by saturated fatty acids and inhibition by docosahexaenoic acid.

Authors:  Daniel H Hwang; Jeong-A Kim; Joo Young Lee
Journal:  Eur J Pharmacol       Date:  2016-04-13       Impact factor: 4.432

3.  Hepatic molecular responses to Bifidobacterium pseudocatenulatum CECT 7765 in a mouse model of diet-induced obesity.

Authors:  A Moya-Pérez; M Romo-Vaquero; F Tomás-Barberán; Y Sanz; M-T García-Conesa
Journal:  Nutr Metab Cardiovasc Dis       Date:  2013-07-04       Impact factor: 4.222

4.  Expression and regulation of leptin receptor proteins in afferent and efferent neurons of the vagus nerve.

Authors:  M Buyse; M L Ovesjö; H Goïot; S Guilmeau; G Péranzi; L Moizo; F Walker; M J Lewin; B Meister; A Bado
Journal:  Eur J Neurosci       Date:  2001-07       Impact factor: 3.386

5.  Leptin: a potential novel antidepressant.

Authors:  Xin-Yun Lu; Chung Sub Kim; Alan Frazer; Wei Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-19       Impact factor: 11.205

Review 6.  Towards a "metabolic" subtype of major depressive disorder: shared pathophysiological mechanisms may contribute to cognitive dysfunction.

Authors:  Celina S Liu; Andre F Carvalho; Roger S McIntyre
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

Review 7.  Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies.

Authors:  M Tanaka; M Yoshida; H Emoto; H Ishii
Journal:  Eur J Pharmacol       Date:  2000-09-29       Impact factor: 4.432

8.  Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome.

Authors:  C Tana; Y Umesaki; A Imaoka; T Handa; M Kanazawa; S Fukudo
Journal:  Neurogastroenterol Motil       Date:  2009-11-10       Impact factor: 3.598

9.  Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia.

Authors:  Changyoun Kim; Dong-Hwan Ho; Ji-Eun Suk; Sungyong You; Sarah Michael; Junghee Kang; Sung Joong Lee; Eliezer Masliah; Daehee Hwang; He-Jin Lee; Seung-Jae Lee
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Leptin/LepRb in the Ventral Tegmental Area Mediates Anxiety-Related Behaviors.

Authors:  Jing Liu; Ming Guo; Xin-Yun Lu
Journal:  Int J Neuropsychopharmacol       Date:  2015-10-05       Impact factor: 5.176

View more
  20 in total

1.  The neurotherapeutic role of a selenium-functionalized quinoline in hypothalamic obese rats.

Authors:  Ethel Antunes Wilhelm; Cristiane Luchese; Karline C Rodrigues; Cristiani F Bortolatto; Ketlyn P da Motta; Renata L de Oliveira; Jaini J Paltian; Roberta Krüger; Silvane S Roman; Silvana P Boeira; Diego Alves
Journal:  Psychopharmacology (Berl)       Date:  2021-03-19       Impact factor: 4.530

Review 2.  Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience.

Authors:  M C Flux; Christopher A Lowry
Journal:  Neurobiol Dis       Date:  2019-08-24       Impact factor: 5.996

3.  Examining the Role of Microbiota in Emotional Behavior: Antibiotic Treatment Exacerbates Anxiety in High Anxiety-Prone Male Rats.

Authors:  M E Glover; J L Cohen; J R Singer; M N Sabbagh; J R Rainville; M T Hyland; C D Morrow; C T Weaver; G E Hodes; Ilan A Kerman; S M Clinton
Journal:  Neuroscience       Date:  2021-02-01       Impact factor: 3.590

4.  Dysbiosis of the gut microbiome is a risk factor for osteoarthritis in older female adults: a case control study.

Authors:  Juanjuan Chen; Anqi Wang; Qi Wang
Journal:  BMC Bioinformatics       Date:  2021-06-03       Impact factor: 3.169

Review 5.  Metabolic and Microbiota Measures as Peripheral Biomarkers in Major Depressive Disorder.

Authors:  Rachael Horne; Jane A Foster
Journal:  Front Psychiatry       Date:  2018-10-22       Impact factor: 4.157

6.  The anxiolytic effect of probiotics: A systematic review and meta-analysis of the clinical and preclinical literature.

Authors:  Daniel J Reis; Stephen S Ilardi; Stephanie E W Punt
Journal:  PLoS One       Date:  2018-06-20       Impact factor: 3.240

7.  The Diversity of the CRISPR-Cas System and Prophages Present in the Genome Reveals the Co-evolution of Bifidobacterium pseudocatenulatum and Phages.

Authors:  Gang Wang; Qian Liu; Zhangming Pei; Linlin Wang; Peijun Tian; Zhenmin Liu; Jianxin Zhao; Hao Zhang; Wei Chen
Journal:  Front Microbiol       Date:  2020-05-26       Impact factor: 5.640

Review 8.  Antidepressive Mechanisms of Probiotics and Their Therapeutic Potential.

Authors:  Shin Jie Yong; Tommy Tong; Jactty Chew; Wei Ling Lim
Journal:  Front Neurosci       Date:  2020-01-14       Impact factor: 4.677

Review 9.  Gut Microbiota and the Neuroendocrine System.

Authors:  Aitak Farzi; Esther E Fröhlich; Peter Holzer
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

Review 10.  Interplay Between the Gut-Brain Axis, Obesity and Cognitive Function.

Authors:  Ana Agustí; Maria P García-Pardo; Inmaculada López-Almela; Isabel Campillo; Michael Maes; Marina Romaní-Pérez; Yolanda Sanz
Journal:  Front Neurosci       Date:  2018-03-16       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.